Medico Remedies Limited Asset Resilience Ratio
Medico Remedies Limited asset resilience ratio. Medico Remedies Limited (MEDICO) has an Asset Resilience Ratio of 1.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medico Remedies Limited (MEDICO) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medico Remedies Limited (2016–2026)
Asset resilience ratio of Medico Remedies Limited from 2016 to 2026. This chart shows how Medico Remedies Limited's Asset Resilience Ratio has changed over time. Read Medico Remedies Limited debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medico Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Medico Remedies Limited.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs18.44 Million | 1.2% |
| Total Liquid Assets | Rs18.44 Million | 1.20% |
Asset Resilience Insights
- Limited Liquidity: Medico Remedies Limited maintains only 1.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medico Remedies Limited Industry Peers by Asset Resilience Ratio
Compare Medico Remedies Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Medico Remedies Limited Asset Resilience Ratio by Year (2016–2026)
Medico Remedies Limited asset resilience ratio by year from 2016 to 2026. The table below shows the annual Asset Resilience Ratio data for Medico Remedies Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 1.20% | Rs18.44 Million ≈ $199.45K |
Rs1.53 Billion ≈ $16.59 Million |
-0.01pp |
| 2025-03-31 | 1.21% | Rs14.51 Million ≈ $156.88K |
Rs1.20 Billion ≈ $12.96 Million |
-0.21pp |
| 2024-03-31 | 1.42% | Rs13.63 Million ≈ $147.41K |
Rs961.95 Million ≈ $10.40 Million |
-0.03pp |
| 2023-03-31 | 1.45% | Rs12.66 Million ≈ $136.88K |
Rs874.48 Million ≈ $9.46 Million |
-0.10pp |
| 2022-03-31 | 1.55% | Rs11.79 Million ≈ $127.49K |
Rs761.90 Million ≈ $8.24 Million |
+0.15pp |
| 2021-03-31 | 1.40% | Rs10.56 Million ≈ $114.18K |
Rs756.21 Million ≈ $8.18 Million |
+0.39pp |
| 2020-03-31 | 1.01% | Rs7.60 Million ≈ $82.19K |
Rs752.69 Million ≈ $8.14 Million |
+0.42pp |
| 2019-03-31 | 0.59% | Rs4.50 Million ≈ $48.67K |
Rs763.09 Million ≈ $8.25 Million |
-0.46pp |
| 2018-03-31 | 1.05% | Rs6.22 Million ≈ $67.29K |
Rs593.85 Million ≈ $6.42 Million |
+1.02pp |
| 2017-03-31 | 0.02% | Rs120.39K ≈ $1.30K |
Rs482.46 Million ≈ $5.22 Million |
+0.36pp |
| 2016-03-31 | -0.33% | Rs-1.52 Million ≈ $-16.39K |
Rs455.43 Million ≈ $4.93 Million |
-- |
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more